4//SEC Filing
Rivkin Anna 4
Accession 0001562180-24-006632
CIK 0001822462other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:02 PM ET
Size
5.6 KB
Accession
0001562180-24-006632
Insider Transaction Report
Form 4
Rivkin Anna
Chief Business Officer
Transactions
- Award
Stock Options (Right to buy)
2024-09-03$7.85/sh+190,000$1,491,500→ 190,000 totalExercise: $7.85Exp: 2034-09-03→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on September 3, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0002035647
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:02 PM ET
- Size
- 5.6 KB